In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies

被引:226
作者
Gai, WP [1 ]
Yuan, HX
Li, XQ
Power, JTH
Blumbergs, PC
Jensen, PH
机构
[1] Flinders Univ S Australia, Dept Physiol, Bedford Pk, SA 5042, Australia
[2] Flinders Univ S Australia, Ctr Neurosci, Bedford Pk, SA 5042, Australia
[3] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia
[4] Inst Med & Vet Sci, Dept Neuropathol, Adelaide, SA, Australia
[5] Univ Aarhus, Dept Med Biochem, Aarhus, Denmark
基金
英国医学研究理事会;
关键词
alpha-synuclein; ubiquitin; lipid; Lewy body; Parkinson's disease; dementia with Lewy bodies;
D O I
10.1006/exnr.2000.7527
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
alpha -Synuclein and ubiquitin are two Lewy body protein components that may play antagonistic roles in the pathogenesis of Lewy bodies. We examined the relationship between alpha -synuclein, ubiquitin, and lipids in Lewy bodies of fixed brain sections or isolated from cortical tissues of dementia with Lewy bodies. Lewy bodies exhibited a range of labeling patterns for alpha -synuclein and ubiquitin, from a homogeneous pattern in which alpha -synuclein and ubiquitin were evenly distributed and overlapped across the inclusion body to a concentric pattern in which alpha -synuclein and ubiquitin were partially segregated, with alpha -synuclein labeling concentrated in the peripheral domain and ubiquitin in the central domain of the Lewy body. Lipids represented a significant component in both homogeneous and concentric Lewy bodies. These results suggest that Lewy bodies are heterogeneous in their subregional composition. The segregation of alpha -synuclein to Lewy body peripheral domain is consistent with the hypothesis that alpha -synuclein is continually deposited onto Lewy bodies. (C) 2000 Academic Press.
引用
收藏
页码:324 / 333
页数:10
相关论文
共 46 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy [J].
Arima, K ;
Uéda, K ;
Sunohara, N ;
Arakawa, K ;
Hirai, S ;
Nakamura, M ;
Tonozuka-Uehara, H ;
Kawai, M .
ACTA NEUROPATHOLOGICA, 1998, 96 (05) :439-444
[3]  
Baba M, 1998, AM J PATHOL, V152, P879
[4]   Degradation of α-synuclein by proteasome [J].
Bennett, MC ;
Bishop, JF ;
Leng, Y ;
Chock, PB ;
Chase, TN ;
Mouradian, MM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :33855-33858
[5]   THE INCIDENCE AND CHARACTERISTICS OF LEWY BODIES IN IDIOPATHIC PARALYSIS AGITANS (PARKINSONS DISEASE) [J].
BETHLEM, J ;
JAGER, WAD .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :74-80
[6]   Extensive axonal Lewy neurites in Parkinson's disease:: a novel pathological feature revealed by α-synuclein immunocytochemistry [J].
Braak, H ;
Sandmann-Keil, D ;
Gai, WP ;
Braak, E .
NEUROSCIENCE LETTERS, 1999, 265 (01) :67-69
[7]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[8]  
Buée L, 1999, BRAIN PATHOL, V9, P681
[9]   THE UBIQUITIN-MEDIATED PROTEOLYTIC PATHWAY [J].
CIECHANOVER, A .
BRAIN PATHOLOGY, 1993, 3 (01) :67-75
[10]   Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
NATURE MEDICINE, 1998, 4 (11) :1318-1320